doi: 10.1093/jncimonographs/lgab011.
- PMID: 34850897
- DOI: 10.1093/jncimonographs/lgab011
Abstract
Cannabis and cannabinoids are increasingly being accessed and used by patients with advanced cancer for various symptoms and general quality of life. Specific symptoms of pain, nausea and vomiting, loss of appetite and cachexia, anxiety, sleep disturbance, and medical trauma are among those that have prompted patients with cancer to use cannabis. This conference report from the National Cancer Institute’s “Cannabis, Cannabinoid and Cancer Research Symposium” on the topic of “Cancer Symptom/Treatment Side Effect Management” is an expert perspective of cannabis intervention for cancer and cancer treatment-related symptoms. The purpose of the symposium was to identify research gaps, describe the need for high-quality randomized prospective studies of medical cannabis for palliative care in patients with cancer, and evaluate the impact of medical cannabis on cancer survivors’ quality of life. Further, education of clinicians and affiliated health-care providers in guiding cancer patients in using cannabis for cancer care would benefit patients. Together, these steps will further aid in refining the use of cannabis and cannabinoids for symptom palliation and improve safety and efficacy for patients.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
[Cannabis and cannabinoids in palliative care].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Jul;62(7):830-835. doi: 10.1007/s00103-019-02967-1.PMID: 31161228 Review. German.
-
State of the science: cannabis and cannabinoids in palliative medicine-the potential.BMJ Support Palliat Care. 2021 Sep;11(3):299-302. doi: 10.1136/bmjspcare-2021-002888. Epub 2021 Apr 26.PMID: 33903260
-
[Cannabinoids in palliative care: Systematic review and meta-analysis of efficacy, tolerability and safety].Schmerz. 2016 Feb;30(1):25-36. doi: 10.1007/s00482-015-0085-2.PMID: 26809975 Review. German.
-
Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).Trials. 2020 Jul 6;21(1):611. doi: 10.1186/s13063-020-04541-6.PMID: 32631447 Free PMC article.
-
Cannabis for Symptom Management in Older Adults.Med Clin North Am. 2020 May;104(3):471-489. doi: 10.1016/j.mcna.2020.01.004.PMID: 32312410 Review.